-
3m 7sPart 4 | Session 2 SURPASS CVOT, HI-PEITHO, SURVIV
-
5m 8sPart 4 | Session 3 Top Takeaways from the 2026 Dyslipidaemia Guidelines
-
2m 21sPart 4 | Session 4 3 ACC.26 Highlights for the Cardiology Pharmacist
-
10m 19s
-
25m 1sPart 1 | Session 1 CHAMPION-AF: LAA Closure vs OAC in AF Outcomes
-
18m 33sPart 1 | Session 2 ALERT: Under-treatment in AS and MR
-
26m 37sPart 1 | Session 3 PRO-TAVI: TAVI With or Without Routine PCI
-
19m 43sPart 1 | Session 4 Dig-RHD: Digoxin in Rheumatic Heart Disease
-
6m 44sPart 2 | Session 1 VESALIUS-CV, KARDINAL, CHIP-BCIS3 & More
-
9m 4sPart 2 | Session 2 CHAMPION-AF, HI-PEITHO, STEMI-DTU
-
5m 51sPart 3 | Session 1 Door to Unload Randomized Clinical Trial
-
5m 58sPart 3 | Session 2 ALL-RISE – Coronary Physiology From Angiography vs Pressure Wire for PCI
-
6m 28s
-
8m 35sPart 3 | Session 4 The STEMI-DTU Trial – Primary Unloading and Delayed Reperfusion in STEMI
-
4m 47s
-
13m 52sPart 3 | Session 6 ACC 2026 with Dr Mehran: Leadership, Vision, and the Future of the College
-
5m 17sPart 3 | Session 7 Heart Failure in 2026: Practical Therapy Lessons From ACC.26
-
6m 14sPart 3 | Session 8 RECOVER-Autonomic - Ivabradine for Post-COVID POTS
-
9m 23sPart 3 | Session 9 ORBITA-CTO - PCI Versus Placebo for Chronic Total Occlusion in Stable Angina
-
7m 21sPart 3 | Session 10 CHIP-BCIS3 – Percutaneous LV Unloading in High-Risk PCI
-
16m 1sPart 3 | Session 11 Dr Reddy & Dr Nair on CHAMPION-AF: Redefining Stroke Prevention
-
7m 26sPart 3 | Session 12 FAST III - FFR vs vFFR to Guide Revascularisation
-
5m 34sPart 3 | Session 13 AI-Based Retinal Imaging for Atherosclerotic Cardiovascular Risk
-
4m 5sPart 3 | Session 14 CORALreef — Durability of Enlicitide for Lipid Lowering in Hypercholesterolaemia
ACC.26 - Dr Anuradha Lala-Trindade (Mount Sinai, New York, NY, US) provides her expert analysis of the most impactful late-breaking clinical trials presented at ACC.26, highlighting studies with the potential to influence clinical practice and shape future cardiovascular care.
Key Late-Breaking Trials Discussed
0:16 – STEMI-DTU: Primary Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardiogenic Shock – Results from the STEMI-Door to Unload Randomized Clinical Trial.
2:24 – GOFRESH: DASH-Patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension – Results from the GoFreshRx Randomized Clinical Trial.
4:05 – HI-PEITHO: Ultrasound-facilitated Catheter-directed Thrombolysis vs Anticoagulation Alone for Acute Intermediate-high-risk Pulmonary Embolism – Primary Results from the HI-PEITHO Randomized Clinical Trial.
From acute MI management to equitable heart failure prevention, and innovation in PE therapy, these are Dr. Lala’s top insights from this year’s ACC Annual Scientific Session.
Editor:Jordan Rance, Mirjam Boros
Videographer:Mike Knight
Support: This is an independent educational video produced by Radcliffe Cardiology.
Keep up-to-date with our video collection from the American College of Cardiology's 75th Annual Scientific Session, bringing you the latest from late-breaking science, featured research, and clinical horizon sessions.
Catch our congress preview and wrap-up in the NVM Cardiology Meeting Reflections series, alongside concise Expert Interviews with leading faculty distilling the key take-home messages for clinical practice — plus in-depth Highlights breaking down the most impactful trials of the meeting.
More from this programme
Part 1
Late-Breaker Discussions
Part 2
Between the Sessions with Dr Purvi Parwani
Part 3
Expert Interviews
Part 4
Highlights
Part 5
Market Watch
Part 6
NVM Cardiology Meeting Reflections
Faculty Biographies
Anuradha Lala
Assistant Professor of Medicine
Dr Anuradha Lala is an assistant professor of medicine at the Zena and Michael A Wiener Cardiovascular Institute and in the Department of Population Health Science and Statistics at Icahn School of Mount Sinai and Mount Sinai Hospital.
Dr Lala is also the Deputy Editor of the Journal of Cardiac Failure.
Comments